Resultado de búsqueda
UMC is a WHO Collaborating Centre that leads the way in pharmacovigilance and drug monitoring. It provides training, guidance and support to countries, manages VigiBase, and conducts signal detection and research.
- Pharmacovigilance Communications
Uppsala Monitoring Centre strives to meet a global need for...
- Research
Developing the science of pharmacovigilance has been a key...
- WHODrug User Area
We can't sign you in. Your browser is currently set to block...
- WHODrug Subscription
How to subscribe. 1. Please click on the enquiry button in...
- VigiLyze
VigiLyze supports the entire signal detection and management...
- VigiBase Services
VigiBase is the richest source of pharmacovigilance data in...
- Self-paced online courses
Uppsala Monitoring Centre offers a range of self-paced...
- About Uppsala Monitoring Centre
Uppsala Monitoring Centre advances the science of...
- Pharmacovigilance Communications
Uppsala Monitoring Centre (UMC), located in Uppsala, Sweden, is the field name for the World Health Organization Collaborating Centre for International Drug Monitoring. UMC works by collecting, assessing and communicating information from member countries' national pharmacovigilance centres in regard to the benefits, harm ...
The WHO Collaborating Centre for International Drug Monitoring is also called the Uppsala Monitoring Centre (UMC). The organisation is an independent foundation which works internationally for patient safety and the safe and effective use of medicines. The foundation provides various services and is involved in scientific research.
UMC is an independent foundation that supports the WHO Programme for International Drug Monitoring and advances the science of pharmacovigilance globally. The website provides information about UMC's activities, products, services, publications, and Vaccine Safety Net portal.
The Uppsala Monitoring Centre (UMC) was the first WHO Collaborating Centre to be established for pharmacovigilance when, in 1978, the scientific and technical responsibility of the WHO Programme for International Drug Monitoring was transferred to Sweden. The Centre is an independent, self-funded, non-profit organisation.